Candel Therapeutics, Inc. (CADL)
Patents
US patents through Dec 31, 2025 · PatentsView, from the USPTO’s Open Data Portal · read Oct 27, 20260 patents granted to the 2 names below, as the owner printed on each patent when it was granted. A later sale, a lapse or an expiry is not read, so this is what was granted to Candel Therapeutics, Inc.’s names, not what it holds today.
6 published
1 published
| Published | Application | Title | Field | Owner as printed |
|---|---|---|---|---|
| Aug 28, 2025 | 2025/0270588 | COMPOSITIONS AND METHODS FOR VIRAL VECTORS | Biotechnology | CANDEL THERAPEUTICS, INC. |
| Jun 5, 2025 | 2025/0177494 | METHODS OF CYTOTOXIC GENE THERAPY TO TREAT TUMORS | Pharmaceuticals | CANDEL THERAPEUTICS, INC. |
| Oct 19, 2023 | 2023/0330194 | METHODS OF CYTOTOXIC GENE THERAPY TO TREAT TUMORS | Pharmaceuticals | CANDEL THERAPEUTICS, INC. |
| Oct 13, 2022 | 2022/0323552 | METHODS OF CYTOTOXIC GENE THERAPY TO TREAT TUMORS | Pharmaceuticals | CANDEL THERAPEUTICS, INC. |
| Jul 14, 2022 | 2022/0218801 | COMBINATION GMCI AND ATRI CANCER TREATMENT | Pharmaceuticals | CANDEL THERAPEUTICS, INC. |
| Jul 7, 2022 | 2022/0211783 | GMCI AND DDRI COMBINATION THERAPY FOR TREATING CANCER | Pharmaceuticals | CANDEL THERAPEUTICS, INC. |
| Dec 2, 2021 | 2021/0369837 | METHODS OF TREATING TIM-3 ELEVATION | Pharmaceuticals | CANDEL THERAPEUTICS, INC. |
A patent is counted where the owner printed on it when it was granted carries the company’s own name, a former name, the name of a subsidiary its annual report lists, or its own name with a patent-holding phrase (Technology Licensing, Intellectual Property and the like), once the legal form, case and punctuation are set aside, and prints a country that name counts in. PatentsView’s data are published under the Creative Commons Attribution 4.0 licence. Source: PatentsView's granted patents and pre-grant publications, disambiguated, from the USPTO's Open Data Portal, through Dec 31, 2025, read Oct 27, 2026.